FR2958500A1 - Insecticide, insect repellent, ovicide, larvicide, nymphicide composition, useful to destruct flying and crawling insects, their eggs, larvae, and nymphs, comprises essential oil, proteolytic enzyme, and amphoteric surfactant - Google Patents
Insecticide, insect repellent, ovicide, larvicide, nymphicide composition, useful to destruct flying and crawling insects, their eggs, larvae, and nymphs, comprises essential oil, proteolytic enzyme, and amphoteric surfactant Download PDFInfo
- Publication number
- FR2958500A1 FR2958500A1 FR1052630A FR1052630A FR2958500A1 FR 2958500 A1 FR2958500 A1 FR 2958500A1 FR 1052630 A FR1052630 A FR 1052630A FR 1052630 A FR1052630 A FR 1052630A FR 2958500 A1 FR2958500 A1 FR 2958500A1
- Authority
- FR
- France
- Prior art keywords
- acid
- acetate
- composition according
- proteolytic enzyme
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 239000000341 volatile oil Substances 0.000 title claims abstract description 19
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 15
- 102000035195 Peptidases Human genes 0.000 title claims abstract description 15
- 239000000077 insect repellent Substances 0.000 title claims abstract description 6
- 241000238631 Hexapoda Species 0.000 title claims description 22
- 235000013601 eggs Nutrition 0.000 title claims description 12
- 230000009193 crawling Effects 0.000 title claims description 3
- 239000002917 insecticide Substances 0.000 title description 21
- 241000118205 Ovicides Species 0.000 title 1
- 239000002280 amphoteric surfactant Substances 0.000 title 1
- 239000002267 larvicidal agent Substances 0.000 title 1
- 239000002253 acid Substances 0.000 claims abstract description 19
- 239000004094 surface-active agent Substances 0.000 claims abstract description 14
- 230000000749 insecticidal effect Effects 0.000 claims abstract description 7
- 230000000974 larvacidal effect Effects 0.000 claims abstract description 5
- 231100000194 ovacidal Toxicity 0.000 claims abstract description 5
- 230000003151 ovacidal effect Effects 0.000 claims abstract description 5
- -1 ketosterol Chemical compound 0.000 claims description 21
- 241000196324 Embryophyta Species 0.000 claims description 12
- 230000001476 alcoholic effect Effects 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 241000218218 Ficus <angiosperm> Species 0.000 claims description 9
- 239000004816 latex Substances 0.000 claims description 9
- 229920000126 latex Polymers 0.000 claims description 9
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 7
- 240000002234 Allium sativum Species 0.000 claims description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 6
- ZEAXBOPUTILUGH-UHFFFAOYSA-N aphyllocladine Natural products S1C(C#CC)=CC=C1C1=CC=C(C=O)S1 ZEAXBOPUTILUGH-UHFFFAOYSA-N 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 235000004611 garlic Nutrition 0.000 claims description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 claims description 6
- LCYXQUJDODZYIJ-UHFFFAOYSA-N pinocarveol Chemical compound C1C2C(C)(C)C1CC(O)C2=C LCYXQUJDODZYIJ-UHFFFAOYSA-N 0.000 claims description 6
- 244000099147 Ananas comosus Species 0.000 claims description 5
- 235000009467 Carica papaya Nutrition 0.000 claims description 5
- 240000006432 Carica papaya Species 0.000 claims description 5
- 235000003142 Sambucus nigra Nutrition 0.000 claims description 5
- 240000006028 Sambucus nigra Species 0.000 claims description 5
- 230000006378 damage Effects 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 235000008995 european elder Nutrition 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 claims description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 4
- XNODZYPOIPVPRF-CGWDHHCXSA-N (2s)-2-methyl-4-[(2r,8r,13r)-2,8,13-trihydroxy-13-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]tridecyl]-2h-furan-5-one Chemical compound O1[C@@H]([C@H](O)CCCCCCCCCCCC)CC[C@@H]1[C@H](O)CCCC[C@H](O)CCCCC[C@@H](O)CC1=C[C@H](C)OC1=O XNODZYPOIPVPRF-CGWDHHCXSA-N 0.000 claims description 4
- PBWRFXQNNGSAQG-UHFFFAOYSA-N (4-methylidene-1-propan-2-yl-3-bicyclo[3.1.0]hexanyl) acetate Chemical compound C=C1C(OC(C)=O)CC2(C(C)C)C1C2 PBWRFXQNNGSAQG-UHFFFAOYSA-N 0.000 claims description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 4
- IRZWAJHUWGZMMT-UHFFFAOYSA-N 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-7-ol Chemical compound CC1=CCC2C(C)(C)C1C2O IRZWAJHUWGZMMT-UHFFFAOYSA-N 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 claims description 4
- 241000723346 Cinnamomum camphora Species 0.000 claims description 4
- FJKKZNIYYVEYOL-UHFFFAOYSA-N Davanone Chemical compound CC(C)=CCC(=O)C(C)C1CCC(C)(C=C)O1 FJKKZNIYYVEYOL-UHFFFAOYSA-N 0.000 claims description 4
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 4
- 235000008730 Ficus carica Nutrition 0.000 claims description 4
- 244000025361 Ficus carica Species 0.000 claims description 4
- 235000009496 Juglans regia Nutrition 0.000 claims description 4
- 240000007049 Juglans regia Species 0.000 claims description 4
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 claims description 4
- 241001454523 Quillaja saponaria Species 0.000 claims description 4
- 235000009001 Quillaja saponaria Nutrition 0.000 claims description 4
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 claims description 4
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 claims description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 4
- 229940116229 borneol Drugs 0.000 claims description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 claims description 4
- 229930008380 camphor Natural products 0.000 claims description 4
- 229960000846 camphor Drugs 0.000 claims description 4
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 claims description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 4
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 claims description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 4
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 claims description 4
- 235000005875 quercetin Nutrition 0.000 claims description 4
- 229960001285 quercetin Drugs 0.000 claims description 4
- USDOQCCMRDNVAH-UHFFFAOYSA-N sigma-cadinene Natural products C1C=C(C)CC2C(C(C)C)CC=C(C)C21 USDOQCCMRDNVAH-UHFFFAOYSA-N 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 4
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 claims description 4
- USDOQCCMRDNVAH-KKUMJFAQSA-N β-cadinene Chemical compound C1C=C(C)C[C@H]2[C@H](C(C)C)CC=C(C)[C@@H]21 USDOQCCMRDNVAH-KKUMJFAQSA-N 0.000 claims description 4
- 240000005020 Acaciella glauca Species 0.000 claims description 3
- 244000235992 Acalypha lanceolata Species 0.000 claims description 3
- 235000007747 Annona muricata Nutrition 0.000 claims description 3
- 240000004749 Annona muricata Species 0.000 claims description 3
- 235000005274 Annona squamosa Nutrition 0.000 claims description 3
- 244000028821 Annona squamosa Species 0.000 claims description 3
- 240000005528 Arctium lappa Species 0.000 claims description 3
- 235000003130 Arctium lappa Nutrition 0.000 claims description 3
- 240000005343 Azadirachta indica Species 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- 241001156386 Carapa Species 0.000 claims description 3
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 3
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 3
- 244000166124 Eucalyptus globulus Species 0.000 claims description 3
- 244000061408 Eugenia caryophyllata Species 0.000 claims description 3
- 235000002598 Inula helenium Nutrition 0.000 claims description 3
- 244000116484 Inula helenium Species 0.000 claims description 3
- 241000592238 Juniperus communis Species 0.000 claims description 3
- 240000007794 Melaleuca viridiflora Species 0.000 claims description 3
- 235000017710 Melaleuca viridiflora Nutrition 0.000 claims description 3
- 235000013500 Melia azadirachta Nutrition 0.000 claims description 3
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 3
- 241001479543 Mentha x piperita Species 0.000 claims description 3
- 235000008582 Pinus sylvestris Nutrition 0.000 claims description 3
- 235000011751 Pogostemon cablin Nutrition 0.000 claims description 3
- 240000002505 Pogostemon cablin Species 0.000 claims description 3
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 3
- 235000008632 Santalum album Nutrition 0.000 claims description 3
- 240000000513 Santalum album Species 0.000 claims description 3
- 240000002114 Satureja hortensis Species 0.000 claims description 3
- 235000007315 Satureja hortensis Nutrition 0.000 claims description 3
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 3
- 241000250966 Tanacetum cinerariifolium Species 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 229960005233 cineole Drugs 0.000 claims description 3
- 239000001771 mentha piperita Substances 0.000 claims description 3
- 210000004877 mucosa Anatomy 0.000 claims description 3
- 239000001839 pinus sylvestris Substances 0.000 claims description 3
- 235000015639 rosmarinus officinalis Nutrition 0.000 claims description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 claims description 2
- AYXPYQRXGNDJFU-QTPLKFIXSA-N (-)-Globulol Chemical compound [C@H]1([C@](CC[C@@H]2[C@H]3C2(C)C)(C)O)[C@H]3[C@H](C)CC1 AYXPYQRXGNDJFU-QTPLKFIXSA-N 0.000 claims description 2
- AYXPYQRXGNDJFU-QUMMREBQSA-N (-)-Globulol Natural products O[C@@]1(C)[C@H]2[C@H]([C@H](C)CC2)[C@@H]2C(C)(C)[C@@H]2CC1 AYXPYQRXGNDJFU-QUMMREBQSA-N 0.000 claims description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims description 2
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 claims description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 2
- NBVJDUCRUAUMAA-CGWDHHCXSA-N (2s)-2-methyl-4-[(2r,8r,11r)-2,8,11-trihydroxy-11-[(2r,5r)-5-[(1r)-1-hydroxypentadecyl]oxolan-2-yl]undecyl]-2h-furan-5-one Chemical compound O1[C@@H]([C@H](O)CCCCCCCCCCCCCC)CC[C@@H]1[C@H](O)CC[C@H](O)CCCCC[C@@H](O)CC1=C[C@H](C)OC1=O NBVJDUCRUAUMAA-CGWDHHCXSA-N 0.000 claims description 2
- URLVCROWVOSNPT-XOTOMLERSA-N (2s)-4-[(13r)-13-hydroxy-13-[(2r,5r)-5-[(2r,5r)-5-[(1r)-1-hydroxyundecyl]oxolan-2-yl]oxolan-2-yl]tridecyl]-2-methyl-2h-furan-5-one Chemical compound O1[C@@H]([C@H](O)CCCCCCCCCC)CC[C@@H]1[C@@H]1O[C@@H]([C@H](O)CCCCCCCCCCCCC=2C(O[C@@H](C)C=2)=O)CC1 URLVCROWVOSNPT-XOTOMLERSA-N 0.000 claims description 2
- UASZOTVHPVEMQR-UHFFFAOYSA-N (4,6,6-trimethyl-7-bicyclo[3.1.1]hept-3-enyl) acetate Chemical compound C1C=C(C)C2C(OC(=O)C)C1C2(C)C UASZOTVHPVEMQR-UHFFFAOYSA-N 0.000 claims description 2
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 claims description 2
- JWQKMEKSFPNAIB-SNVBAGLBSA-N (5r)-1-methyl-5-prop-1-en-2-ylcyclohexene Chemical compound CC(=C)[C@@H]1CCC=C(C)C1 JWQKMEKSFPNAIB-SNVBAGLBSA-N 0.000 claims description 2
- 239000001306 (7E,9E,11E,13E)-pentadeca-7,9,11,13-tetraen-1-ol Substances 0.000 claims description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- IXELFRRANAOWSF-FNORWQNLSA-N (E)-Ajoene Chemical compound C=CCSS\C=C\CS(=O)CC=C IXELFRRANAOWSF-FNORWQNLSA-N 0.000 claims description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 2
- DCSCXTJOXBUFGB-JGVFFNPUSA-N (R)-(+)-Verbenone Natural products CC1=CC(=O)[C@@H]2C(C)(C)[C@H]1C2 DCSCXTJOXBUFGB-JGVFFNPUSA-N 0.000 claims description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 2
- DCSCXTJOXBUFGB-SFYZADRCSA-N (R)-(+)-verbenone Chemical compound CC1=CC(=O)[C@H]2C(C)(C)[C@@H]1C2 DCSCXTJOXBUFGB-SFYZADRCSA-N 0.000 claims description 2
- JGINTSAQGRHGMG-NLJYZETGSA-N (z)-5-[(1s,5s,6r)-4,6-dimethyl-6-bicyclo[3.1.1]hept-3-enyl]-2-methylpent-2-en-1-ol Chemical compound C1[C@@H]2[C@@](CC/C=C(CO)/C)(C)[C@H]1CC=C2C JGINTSAQGRHGMG-NLJYZETGSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- RVVLUQPXASICPK-UHFFFAOYSA-N 1-[5-(5-prop-1-ynylthiophen-2-yl)thiophen-2-yl]ethane-1,2-diol Chemical compound S1C(C#CC)=CC=C1C1=CC=C(C(O)CO)S1 RVVLUQPXASICPK-UHFFFAOYSA-N 0.000 claims description 2
- UPOWHCBUDJLAIB-UHFFFAOYSA-N 1-[5-(5-prop-1-ynylthiophen-2-yl)thiophen-2-yl]ethanone Chemical compound S1C(C#CC)=CC=C1C1=CC=C(C(C)=O)S1 UPOWHCBUDJLAIB-UHFFFAOYSA-N 0.000 claims description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 2
- TYIOVYZMKITKRO-UHFFFAOYSA-N 2-[hexadecyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O TYIOVYZMKITKRO-UHFFFAOYSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- HVFIEGOJQDOBGC-UHFFFAOYSA-N Annoglacin A Natural products O1C(C(O)CCCCCCCCCCCC)CCC1C(O)CCCCC(O)CCCCCCCC(O)CC1=CC(C)OC1=O HVFIEGOJQDOBGC-UHFFFAOYSA-N 0.000 claims description 2
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 2
- VOOFFTMORIBISQ-UMRVURNHSA-N Arctiopicrin Chemical compound OCC(C)C(=O)O[C@H]1C\C(C)=C\CC\C(CO)=C\[C@H]2OC(=O)C(=C)[C@H]12 VOOFFTMORIBISQ-UMRVURNHSA-N 0.000 claims description 2
- VOOFFTMORIBISQ-XLGWXLBMSA-N Arctiopicrin Natural products O=C(O[C@@H]1[C@H]2C(=C)C(=O)O[C@H]2/C=C(/CO)\CC/C=C(/C)\C1)[C@H](CO)C VOOFFTMORIBISQ-XLGWXLBMSA-N 0.000 claims description 2
- 240000002791 Brassica napus Species 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 2
- 244000107602 Corymbia citriodora Species 0.000 claims description 2
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 claims description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 2
- 235000004722 Eucalyptus citriodora Nutrition 0.000 claims description 2
- 239000005770 Eugenol Substances 0.000 claims description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 claims description 2
- WIQMWNKYSYJIQG-UHFFFAOYSA-N Juglon Natural products C1=CC(O)=C2C(=O)C(OC)=C(C)C(=O)C2=C1 WIQMWNKYSYJIQG-UHFFFAOYSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- CKZXONNJVHXSQM-UHFFFAOYSA-N Ledol Natural products CC(C)C1CCC(C)(O)C2C3CC(C)CC123 CKZXONNJVHXSQM-UHFFFAOYSA-N 0.000 claims description 2
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 claims description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 claims description 2
- RXBQNMWIQKOSCS-UHFFFAOYSA-N Myrthenol Natural products C1C2C(C)(C)C1CC=C2CO RXBQNMWIQKOSCS-UHFFFAOYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical group C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 claims description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 2
- 229930186743 Quercetol Natural products 0.000 claims description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- 229930185210 Saponoside Natural products 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- UXZIDIYMFIBDKT-UHFFFAOYSA-N Sylvestrene Natural products CC(=C)C1CCCC(C)=C1 UXZIDIYMFIBDKT-UHFFFAOYSA-N 0.000 claims description 2
- 239000005844 Thymol Substances 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims description 2
- QUHYUSAHBDACNG-UHFFFAOYSA-N acerogenin 3 Natural products C1=CC(O)=CC=C1CCCCC(=O)CCC1=CC=C(O)C=C1 QUHYUSAHBDACNG-UHFFFAOYSA-N 0.000 claims description 2
- IXELFRRANAOWSF-CYBMUJFWSA-N ajoene Natural products C=CCSSC=CC[S@](=O)CC=C IXELFRRANAOWSF-CYBMUJFWSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 claims description 2
- XNODZYPOIPVPRF-BGXDYLHZSA-N annonacin A Natural products O=C1C(C[C@H](O)CCCCC[C@H](O)CCCC[C@H](O)[C@H]2O[C@H]([C@H](O)CCCCCCCCCCCC)CC2)=C[C@H](C)O1 XNODZYPOIPVPRF-BGXDYLHZSA-N 0.000 claims description 2
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 claims description 2
- 235000008714 apigenin Nutrition 0.000 claims description 2
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 claims description 2
- 229940117893 apigenin Drugs 0.000 claims description 2
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 claims description 2
- 235000021028 berry Nutrition 0.000 claims description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 2
- 229940115397 bornyl acetate Drugs 0.000 claims description 2
- 235000004883 caffeic acid Nutrition 0.000 claims description 2
- 229940074360 caffeic acid Drugs 0.000 claims description 2
- 229930006739 camphene Natural products 0.000 claims description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 claims description 2
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 claims description 2
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 claims description 2
- 235000007746 carvacrol Nutrition 0.000 claims description 2
- IRAQOCYXUMOFCW-CXTNEJHOSA-N cedrene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1C(C)=CC2 IRAQOCYXUMOFCW-CXTNEJHOSA-N 0.000 claims description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 2
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 2
- 229940074393 chlorogenic acid Drugs 0.000 claims description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 claims description 2
- 235000013985 cinnamic acid Nutrition 0.000 claims description 2
- 229930016911 cinnamic acid Natural products 0.000 claims description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 2
- IXELFRRANAOWSF-UHFFFAOYSA-N cis-ajoene Natural products C=CCSSC=CCS(=O)CC=C IXELFRRANAOWSF-UHFFFAOYSA-N 0.000 claims description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 2
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 claims description 2
- 229960004106 citric acid Drugs 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 235000000983 citronellal Nutrition 0.000 claims description 2
- 229930003633 citronellal Natural products 0.000 claims description 2
- 235000000484 citronellol Nutrition 0.000 claims description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 claims description 2
- URLVCROWVOSNPT-QTTMQESMSA-N desacetyluvaricin Natural products O=C1C(CCCCCCCCCCCC[C@@H](O)[C@H]2O[C@@H]([C@@H]3O[C@@H]([C@@H](O)CCCCCCCCCC)CC3)CC2)=C[C@H](C)O1 URLVCROWVOSNPT-QTTMQESMSA-N 0.000 claims description 2
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 claims description 2
- 150000001993 dienes Chemical class 0.000 claims description 2
- 229960003720 enoxolone Drugs 0.000 claims description 2
- 229960002217 eugenol Drugs 0.000 claims description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 2
- 235000001785 ferulic acid Nutrition 0.000 claims description 2
- 229940114124 ferulic acid Drugs 0.000 claims description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 2
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 claims description 2
- YDLBHMSVYMFOMI-SDFJSLCBSA-N germacrene Chemical compound CC(C)[C@H]1CC\C(C)=C\CC\C(C)=C\C1 YDLBHMSVYMFOMI-SDFJSLCBSA-N 0.000 claims description 2
- 229930001612 germacrene Natural products 0.000 claims description 2
- NKIWRYQBASKLRK-UHFFFAOYSA-N globulol Natural products CC1CCC2CC(C)(O)CC3C(C12)C3(C)C NKIWRYQBASKLRK-UHFFFAOYSA-N 0.000 claims description 2
- NBVJDUCRUAUMAA-VFCVDYGLSA-N goniothalamicin Natural products O=C1C(C[C@H](O)CCCCC[C@@H](O)CC[C@@H](O)[C@@H]2O[C@H]([C@H](O)CCCCCCCCCCCCCC)CC2)=C[C@@H](C)O1 NBVJDUCRUAUMAA-VFCVDYGLSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- CVUANYCQTOGILD-QVHKTLOISA-N isoalantolactone Chemical compound C1CCC(=C)[C@@H]2C[C@@H]3C(=C)C(=O)O[C@@H]3C[C@]21C CVUANYCQTOGILD-QVHKTLOISA-N 0.000 claims description 2
- CVUANYCQTOGILD-UHFFFAOYSA-N isoalantolactone Natural products C1CCC(=C)C2CC3C(=C)C(=O)OC3CC21C CVUANYCQTOGILD-UHFFFAOYSA-N 0.000 claims description 2
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- KQPYUDDGWXQXHS-UHFFFAOYSA-N juglone Chemical compound O=C1C=CC(=O)C2=C1C=CC=C2O KQPYUDDGWXQXHS-UHFFFAOYSA-N 0.000 claims description 2
- 235000008777 kaempferol Nutrition 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 235000001510 limonene Nutrition 0.000 claims description 2
- 229940087305 limonene Drugs 0.000 claims description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000009498 luteolin Nutrition 0.000 claims description 2
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 claims description 2
- 229940041616 menthol Drugs 0.000 claims description 2
- 229930007503 menthone Natural products 0.000 claims description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 2
- 229940116837 methyleugenol Drugs 0.000 claims description 2
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 claims description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- CKMXAIVXVKGGFM-UHFFFAOYSA-N p-cumic acid Chemical compound CC(C)C1=CC=C(C(O)=O)C=C1 CKMXAIVXVKGGFM-UHFFFAOYSA-N 0.000 claims description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 2
- GGHMUJBZYLPWFD-CUZKYEQNSA-N patchouli alcohol Chemical compound C1C[C@]2(C)[C@@]3(O)CC[C@H](C)[C@@H]2C[C@@H]1C3(C)C GGHMUJBZYLPWFD-CUZKYEQNSA-N 0.000 claims description 2
- 229940100595 phenylacetaldehyde Drugs 0.000 claims description 2
- 229930006721 pinocarveol Natural products 0.000 claims description 2
- 229920001197 polyacetylene Polymers 0.000 claims description 2
- 150000004291 polyenes Chemical class 0.000 claims description 2
- 229920001021 polysulfide Polymers 0.000 claims description 2
- 239000005077 polysulfide Substances 0.000 claims description 2
- 150000008117 polysulfides Polymers 0.000 claims description 2
- GGHMUJBZYLPWFD-UHFFFAOYSA-N rac-patchouli alcohol Natural products C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 claims description 2
- 229930013258 santalene Natural products 0.000 claims description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims description 2
- 229940032091 stigmasterol Drugs 0.000 claims description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims description 2
- 235000016831 stigmasterol Nutrition 0.000 claims description 2
- 239000010902 straw Substances 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 229930006978 terpinene Natural products 0.000 claims description 2
- 150000003507 terpinene derivatives Chemical class 0.000 claims description 2
- 229940116411 terpineol Drugs 0.000 claims description 2
- 229960000790 thymol Drugs 0.000 claims description 2
- LCYXQUJDODZYIJ-VGMNWLOBSA-N trans-Pinocarveol Natural products C1[C@@H]2C(C)(C)[C@H]1C[C@H](O)C2=C LCYXQUJDODZYIJ-VGMNWLOBSA-N 0.000 claims description 2
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 claims description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 2
- DCSCXTJOXBUFGB-UHFFFAOYSA-N verbenone Natural products CC1=CC(=O)C2C(C)(C)C1C2 DCSCXTJOXBUFGB-UHFFFAOYSA-N 0.000 claims description 2
- KWFJIXPIFLVMPM-UHFFFAOYSA-N α-santalene Chemical compound C1C2C3(C)C2CC1C3(C)CCC=C(C)C KWFJIXPIFLVMPM-UHFFFAOYSA-N 0.000 claims description 2
- WUOACPNHFRMFPN-VIFPVBQESA-N (R)-(+)-alpha-terpineol Chemical compound CC1=CC[C@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-VIFPVBQESA-N 0.000 claims 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- 235000016068 Berberis vulgaris Nutrition 0.000 claims 1
- 241000335053 Beta vulgaris Species 0.000 claims 1
- 235000019482 Palm oil Nutrition 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 229940099690 malic acid Drugs 0.000 claims 1
- 239000002540 palm oil Substances 0.000 claims 1
- WZAMDSBJONFHAO-UHFFFAOYSA-N quercetin 3-alpha-L-rhamnofuranoside Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(=C)CCC=C(C)C)C4CCC3C21C WZAMDSBJONFHAO-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 12
- 241000255925 Diptera Species 0.000 description 26
- 238000012360 testing method Methods 0.000 description 13
- 230000009471 action Effects 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 241000894007 species Species 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 230000001418 larval effect Effects 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000002676 xenobiotic agent Substances 0.000 description 6
- 229920002101 Chitin Polymers 0.000 description 5
- 108090000371 Esterases Proteins 0.000 description 5
- 241000256182 Anopheles gambiae Species 0.000 description 4
- 241000256059 Culex pipiens Species 0.000 description 4
- 241000257303 Hymenoptera Species 0.000 description 4
- 241000256602 Isoptera Species 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000029052 metamorphosis Effects 0.000 description 4
- 241001674044 Blattodea Species 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000001665 lethal effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 241000256118 Aedes aegypti Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 241000819999 Nymphes Species 0.000 description 2
- 241000258242 Siphonaptera Species 0.000 description 2
- 241000255628 Tabanidae Species 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- PXOYOCNNSUAQNS-AGNJHWRGSA-N alantolactone Chemical compound C1[C@H]2OC(=O)C(=C)[C@H]2C=C2[C@@H](C)CCC[C@@]21C PXOYOCNNSUAQNS-AGNJHWRGSA-N 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 210000000609 ganglia Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- OWFJMIVZYSDULZ-PXOLEDIWSA-N (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O OWFJMIVZYSDULZ-PXOLEDIWSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- MYZPBDIATBBLPX-UHFFFAOYSA-N (Z)-lyratyl acetate Natural products CC(=O)OCC(C)=CC(C=C)C(C)=C MYZPBDIATBBLPX-UHFFFAOYSA-N 0.000 description 1
- MYZPBDIATBBLPX-JXMROGBWSA-N (s,z)-lyratol acetate Chemical compound CC(=O)OC\C(C)=C\C(C=C)C(C)=C MYZPBDIATBBLPX-JXMROGBWSA-N 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 241000256111 Aedes <genus> Species 0.000 description 1
- 241000256173 Aedes albopictus Species 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 241000256186 Anopheles <genus> Species 0.000 description 1
- 241000256056 Anopheles arabiensis Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000238657 Blattella germanica Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 241000544656 Cedrus atlantica Species 0.000 description 1
- 241000255930 Chironomidae Species 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000256686 Lasius <genus> Species 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- 241000254022 Locusta migratoria Species 0.000 description 1
- TXJXQVRSITVNSI-UHFFFAOYSA-N Lyratyl acetate Natural products CC(C)C(C=C)C=C(/C)COC(=O)C TXJXQVRSITVNSI-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241001509970 Reticulitermes <genus> Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000414043 Vetiveria Species 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- PXOYOCNNSUAQNS-UHFFFAOYSA-N alantolactone Natural products C1C2OC(=O)C(=C)C2C=C2C(C)CCCC21C PXOYOCNNSUAQNS-UHFFFAOYSA-N 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001534 vitelline membrane Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pest Control & Pesticides (AREA)
- Virology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
L'invention porte sur une composition insecticide, insectifuge, ovicide, larvicide, nymphicide, comprenant : - au moins une huile essentielle comprenant au moins une fonction acide; - au moins une enzyme protéolytique ; - un tensioactif, de préférence amphotère; - éventuellement, une ou plusieurs alcoolatures, sur son procédé de préparation et sur son utilisation.The invention relates to an insecticidal, insect repellent, ovicidal, larvicidal, and nymphicidal composition comprising: at least one essential oil comprising at least one acid function; at least one proteolytic enzyme; a surfactant, preferably amphoteric; - optionally, one or more alcoholates, on its preparation process and on its use.
Description
PREPARATION INSECTICIDE, INSECTIFUGE, OVICIDE, LARVICIDE, NYMPHICIDE La présente invention concerne une préparation insecticide, insectifuge, ovicide, larvicide et nymphicide composée d'huiles essentielles d'un chémotype défini par chromatographie en phase gazeuse et par spectrométrie de masse, d'alcoolatures de feuilles et ou de fruits, de bulbes, d'espèces végétales définies et de solutions alcooliques d'enzymes protéolytiques végétales, de tensioactifs d'origine végétale. La grande majorité des préparations insecticides est destinée surtout à la destruction de l'insecte adulte. Très peu de préparations s'adressent à la destruction des différents stades de la métamorphose des insectes piqueurs et suceurs tels que les moustiques, mouches, moucherons, tiques, puces, taons. En effet, l'éradication de ces insectes dans leur site de développement fait appel à l'utilisation de plusieurs préparations différentes dont certaines contiennent des molécules dont le maniement délicat peut s'avérer préjudiciable pour la santé des animaux domestiques ou les animaux d'élevage ainsi que ceux destinés à la consommation humaine. D'autre part, il n'est pas rare que les produits utilisés contiennent des molécules antagonistes susceptibles de générer des réactions chimiques aboutissant à de nouveaux composés dont les effets nocifs sont méconnus. La reproduction de la plupart des insectes nuisibles se déroule selon un schéma général d'évolution allant de l'oeuf à l'individu adulte en passant par le stade larvaire et nymphale. La lutte anti-vectorielle doit donc s'exercer sur tous ces stades, sur le site de ponte qui est presque toujours le site larvaire ainsi que sur le biotope de l'adulte qui est plus vaste. The present invention relates to an insecticidal, insect repellent, ovicidal, larvicidal and nymphicidal preparation composed of essential oils of a chemotype defined by gas chromatography and by mass spectrometry, alcoholic beverages. leaves and or fruits, bulbs, defined plant species and alcoholic solutions of plant proteolytic enzymes, surfactants of vegetable origin. The vast majority of insecticide preparations are intended primarily for the destruction of the adult insect. Very few preparations are aimed at destroying the different stages of metamorphosis of biting and sucking insects such as mosquitoes, flies, midges, ticks, fleas, horseflies. Indeed, the eradication of these insects in their development site requires the use of several different preparations, some of which contain molecules whose delicate handling can be detrimental to the health of domestic animals or livestock as well as those intended for human consumption. On the other hand, it is not uncommon for the products used to contain antagonistic molecules capable of generating chemical reactions resulting in new compounds whose harmful effects are unknown. The reproduction of most pests takes place according to a general pattern of evolution from the egg to the adult to the larval and pupal stages. Vector control must therefore be exercised at all stages, at the nesting site, which is almost always the larval site, and at the adult biotope, which is larger.
En règle générale peu de produits ont un impact sur les oeufs, du fait de leur composition ; la destruction des larves s'avère difficile du fait de la non sélectivité des insecticides utilisés. Par exemple, l'emploi de Bacillus thuringiensis var.israellensis est d'un maniement difficile et coûteux et surtout ne met pas forcément à l'abri de l'apparition d'un mécanisme de résistance. Quant à la lutte anti-vectorielle concernant l'adulte, elle repose uniquement sur les traitements des sites d'éclosion et également sur divers moyens (piège, épandage, traitement des zones humides). Le traitement larvaire, soit par contact, soit par ingestion est très aléatoire. As a rule, few products have an impact on eggs because of their composition; the destruction of the larvae proves difficult because of the non-selectivity of the insecticides used. For example, the use of Bacillus thuringiensis var. Israellensis is difficult and expensive handling and above all does not necessarily protect the appearance of a mechanism of resistance. As for vector control for adults, it relies solely on the treatment of hatch sites and also on various means (trap, spreading, treatment of wetlands). The larval treatment, either by contact or by ingestion is very random.
En effet, cela implique la présence du produit lors de l'éclosion et au moment où la larve se nourrit dans la mesure où les conditions atmosphériques sont stables, faute de quoi le traitement devient inefficace Concernant le stade nymphale, peu de produits ont une action sur la nymphe, notamment celle des moustiques, car la métamorphose est de courte durée, de 24 à 48 heures et surtout la nymphe ne se nourrit pas et vit à la surface du gîte larvaire en respirant par deux trompettes situées sur son céphalo-thorax. Indeed, this implies the presence of the product during the hatching and at the moment when the larva feeds to the extent that the atmospheric conditions are stable, otherwise the treatment becomes ineffective With regard to the nymphal stage, few products have an action on the nymph, especially that of mosquitoes, because the metamorphosis is of short duration, from 24 to 48 hours and especially the nymph does not feed and lives on the surface of the larval shelter while breathing by two trumpets located on its cephalo-thorax.
Tous ces produits utilisés pour les combattre ne sont pas dépourvus de toxicité immédiate, sans compter que les différentes préparations insecticides utilisées pour chaque stade de la métamorphose constituent de nouveaux xénobiotiques venant s'ajouter aux xénobiotiques environnementaux et naturels, partiellement à l'origine de l'apparition des phénomènes de résistance. L'étude de la résistance des moustiques aux insecticides a été réalisée sur plusieurs espèces et a mis en évidence que cette résistance est liée non seulement à l'apparition de mécanismes qui empêchent les insecticides d'atteindre leur cible ou qui rendent la cible moins sensible à ceux-ci, mais aussi à l'action de l'homme sur l'environnement. Les espèces principalement étudiées sont: Culex pipiens, Culex quinquefaciatus, Anopheles arabiensis, Anopheles funestes, Aedes aegypti, Anopheles gambiae. Les études ont été menées aussi bien en milieu tropical tempéré qu'en Afrique. On sait que les principales espèces de moustiques responsables de la transmission de maladies (dingue, paludisme, fièvre jaune, shinkungunya, etc.) sont devenues résistantes aux principaux insecticides utilisés (organophosphorés, carbamates, pyréthrinoïdes, etc.) dans la lutte anti-vectorielle. All these products used to combat them are not devoid of immediate toxicity, besides the different insecticidal preparations used for each stage of the metamorphosis are new xenobiotics in addition to the environmental and natural xenobiotics, partially at the origin of the appearance of resistance phenomena. The study of mosquito resistance to insecticides has been carried out on several species and has shown that this resistance is linked not only to the appearance of mechanisms that prevent insecticides from reaching their target or that make the target less sensitive. to these, but also to the action of man on the environment. The main species studied are Culex pipiens, Culex quinquefaciatus, Anopheles arabiensis, Anopheles funestes, Aedes aegypti, Anopheles gambiae. Studies have been conducted in both tropical temperate and Africa. We know that the main mosquito species responsible for the transmission of diseases (crazy, malaria, yellow fever, shinkungunya, etc.) have become resistant to the main insecticides used (organophosphorus, carbamates, pyrethroids, etc.) in the fight against vector .
Ces travaux ont mis en évidence la production accrue d'estérases (enzymes naturellement produites par les insectes) qui hydrolysent l'insecticide, l'empêchant d'atteindre sa cible ; il s'agit d'un mécanisme de détoxication par métabolisation de l'insecticide. This work has highlighted the increased production of esterases (enzymes naturally produced by insects) that hydrolyze the insecticide, preventing it from reaching its target; it is a detoxification mechanism by metabolizing the insecticide.
Chez certaines souches résistantes, la production d'estérases en grande quantité est le principal mécanisme à l'origine de la résistance, non pas qualitativement mais quantitativement, à l'inverse des moustiques sensibles chez lesquels la production d'estérases est très faible et n'empêche pas l'insecticide de pénétrer, de circuler et d'agir. Les gênes codant pour les estérases s'expriment dans la paroi du tube digestif, dans la zone cellulaire cutanée sous hypodermique, qui sont les voies de pénétration de ce dernier, les ganglions thoraciques et cérébraux étant les organes cibles. Les estérases sont produites en excès soit par un processus d'amplification du nombre de copies, soit par une augmentation de leur expression. Un autre mécanisme de résistance notamment aux organo-phosphorés (OP) et aux carbamates est dû à la modification spatiale des molécules d'acétylcholinestérase (Ace) des moustiques, qui sont les cibles moléculaires de ces insecticides, modification induisant une insensibilité de l'Ace à l'action de ces derniers. In some resistant strains, the production of esterases in large quantities is the main mechanism causing the resistance, not qualitatively but quantitatively, in contrast to sensitive mosquitos in which the esterase production is very low and n prevents the insecticide from entering, circulating and acting. The genes coding for esterases are expressed in the wall of the digestive tract, in the hypodermic cutaneous skin zone, which are the penetration pathways of the latter, the thoracic and cerebral ganglia being the target organs. Esterases are produced in excess either by a process of amplification of the number of copies, or by an increase in their expression. Another mechanism of resistance in particular to organophosphorus (OP) and carbamates is due to the spatial modification of the acetylcholinesterase (Ace) molecules of mosquitoes, which are the molecular targets of these insecticides, a modification inducing insensitivity of Ace. to the action of these.
L'étude des différents phénotypes de résistance et des changements génétiques qui leur sont associés permet de comprendre comment se fait cette adaptation. En fait, les moustiques ne mutent pas afin de résister aux insecticides ; de nombreuses mutations préexistent chez plusieurs espèces, les mutations ne sont donc pas engendrées, mais sélectionnées par le milieu. La fréquence des moustiques porteurs de ces mutations augmente ; l'existence de flux génétiques permet d'expliquer la dispersion des gênes de résistance. C'est ainsi que s'explique qu'une même mutation était présente dans le gêne Acel chez différentes espèces de moustiques. Cette mutation (G 119S), présente à 2 reprises chez Culex pipiens, a été retrouvée chez la majorité des moustiques, toutes espèces confondues. La résistance aux pyréthrinoïdes chez Anopheles gambiae, vecteur du paludisme et d'Aedes albopictus vecteur du shikungunya, est associée à la mutation moléculaire de la cible de cette famille d'insecticide, le gêne Kdr. D'autres mécanismes expliquent la résistance des moustiques à la totalité des insecticides. C'est la résistance larvaire principalement due à la présence dans les sites larvaires, de xénobiotiques environnementaux (herbicides, pesticides, etc.) et de xénobiotiques naturels (polyphénols végétaux) qui induisent une tolérance accrue aux biocides en facilitant la sélection des gênes de résistance, gênes impliqués dans les mécanismes de réponse à ces xénobiotiques par des réactions moléculaires adaptatives aux polluants et aux xénobiotiques naturels d'où production de résistances croisées. En conclusion, l'utilisation des biocides impliqués dans la lutte antivectorielle a montré leurs limites et leurs dangers, conduisant à l'apparition irréversible de résistances, à la modification de l'environnement et à l'apparition de pathologies chez l'homme, comme a montré l'action des organophosphorés par l'inhibition de l'acéthylcholinestérase dans les érythrocytes chez le personnel chargé des applications de cette famille d'insecticide ; démontrée par la réduction de l'activité enzymatique qui a largement dépassé le seuil biologique recommandé par l'OMS, réduction enzymatique traduite par une hypocholinestérasémie importante. La plupart des insecticides sont destinés à agir surtout sur l'insecte adulte. Quand on sait que de nombreux insectes piqueurs comme les moustiques, les mouches, les puces, les tiques, les taons ont développé de multiples mécanismes de résistance à l'action des insecticides et que les femelles de ces insectes pondent de 50 à 200 oeufs chacune, on comprend dès lors que si très peu de préparations agissent sur tous les stades de la métamorphose, de nombreux individus arriveront à l'âge adulte et engendreront de nouvelles générations d'insectes résistants. On sait que l'exo-squelette de tous les insectes est constitué de 25% de chitine (qui est un polymère, plus précisément un acétylglucosamine poly-51-,4-N- acétylglucosamine) et de 75% de carbonate de calcium sous forme amorphe, combiné à la chitine et qui confère à la carapace des insectes sa rigidité ainsi que son imperméabilité et c'est ce qui permet aux insectes et aux larves aquatiques de flotter. The study of the different phenotypes of resistance and the genetic changes associated with them makes it possible to understand how this adaptation is done. In fact, mosquitoes do not mutate to resist insecticides; many mutations preexist in several species, mutations are not generated, but selected by the medium. The frequency of mosquitoes carrying these mutations increases; the existence of genetic flows makes it possible to explain the dispersion of the genes of resistance. This explains why the same mutation was present in the Acel gene in different mosquito species. This mutation (G 119S), present twice in Culex pipiens, was found in the majority of mosquitoes, all species combined. Resistance to pyrethroids in Anopheles gambiae, vector of malaria and Aedes albopictus shikungunya vector, is associated with the molecular mutation of the target of this family of insecticide, the Kdr discomfort. Other mechanisms explain mosquito resistance to all insecticides. It is the larval resistance mainly due to the presence in the larval sites, environmental xenobiotics (herbicides, pesticides, etc.) and natural xenobiotics (plant polyphenols) which induce an increased tolerance to biocides by facilitating the selection of resistance genes. , genes involved in the mechanisms of response to these xenobiotics by adaptive molecular reactions to pollutants and natural xenobiotics resulting in production of cross-resistance. In conclusion, the use of biocides involved in vector control has shown their limits and their dangers, leading to the irreversible onset of resistance, the modification of the environment and the appearance of pathologies in humans, such as has shown the action of organophosphorus by the inhibition of acethylcholinesterase in erythrocytes in personnel responsible for applications of this family of insecticide; demonstrated by the reduction of enzymatic activity that has significantly exceeded the biological threshold recommended by WHO, enzyme reduction translated by a significant hypocholinesteremia. Most insecticides are intended to act primarily on the adult insect. When we know that many stinging insects such as mosquitoes, flies, fleas, ticks, horseflies have developed multiple mechanisms of resistance to the action of insecticides and that the females of these insects lay from 50 to 200 eggs each It is therefore understandable that if very few preparations act on all stages of metamorphosis, many individuals will reach adulthood and generate new generations of resistant insects. It is known that the exoskeleton of all insects consists of 25% chitin (which is a polymer, more specifically acetylglucosamine poly-51-, 4-N-acetylglucosamine) and 75% calcium carbonate in form. amorphous, combined with chitin, which gives the shell of insects rigidity and impermeability and this allows aquatic insects and larvae to float.
D'autre part, la morphologie de la plupart des insectes (mouches, moustiques, fourmis, criquets, etc), surtout au niveau des parties renfermant les organes cibles (thorax, abdomen) des insecticides, s'est adaptée par un épaississement des strates de chitine aux agressions physiques et chimiques. Comme la plupart des insecticides agissent par contact ou par ingestion et ont comme organe cible le système nerveux par l'intermédiaire des ganglions thoraciques et céphaliques, ils ont provoqué chez beaucoup d'insectes des résistances et notamment chez les moustiques. Il fallait donc trouver une préparation insecticide qui aurait une action non seulement sur les organes habituels, mais aussi sur d'autres organes et systèmes afin de contrecarrer l'apparition des phénomènes de résistance en induisant une action létale rapide par la destruction de ces organes et systèmes et également sur tous les stades de développement de l'insecte. C'est ce qui fait l'objet de la présente invention. La composition selon l'invention comprend : - au moins une huile essentielle comprenant au moins une fonction acide; - au moins une enzyme protéolytique; - un tensioactif, de préférence amphotère, - éventuellement une ou plusieurs alcoolatures. Selon un mode de réalisation avantageux, tous les éléments constitutifs de la composition sont d'origine végétale, en particulier l'enzyme protéolytique et le tensioactif. Selon l'invention, la composition comprend au moins une huile essentielle. Elle peut comprendre un mélange pouvant aller jusqu'à 10 huiles essentielles. Au-delà de 10 huiles, l'intérêt économique est moindre. Un mélange de 4, 5, 6 ou 7 huiles essentielles donne de bons résultats. Ces huiles essentielles sont choisies dans le groupe comprenant Inula helenium, Acalypha indica, Eucalyptus globulus, Vetveria zizanoîdes, Rollina mucosa, Mentha piperita, Arctium lappa, Eugenia caryophyllata, Pinus sylvestris, Juniperus communis, Melaleuca viridiflora, Carapa guyanensis, Annona muricata, Annona squamosa, Sapendus mukorossi, Pogostemon cablin, Rosmarinus officinalis, Santalum album, Tanacetum vulgare, Tanacetum cinerariifolium, Allium sativum, Satureja montana, Quillaja saponaria, Eucalyptus citriodora. Afin de majorer l'effet létal, on ajoute à la préparation selon l'invention, de la poudre ou une solution alcoolique de latex de Carica papaya et ou de latex de Anana comosus et ou de latex de Ficus genius, de Ficus glabadia, de Ficus carica. Le latex de ces espèces végétales contient de puissantes enzymes protéolytiques, à savoir la papaïne pour Carica papaya, la broméline pour Anana comosus et la ficine pour Ficus genius, Ficus glabatia, Ficus carica. On the other hand, the morphology of most insects (flies, mosquitoes, ants, locusts, etc.), especially at the level of the parts containing the target organs (thorax, abdomen) of the insecticides, adapted by a thickening of the strata. chitin to physical and chemical aggressions. As most insecticides act by contact or by ingestion and have as a target organ the nervous system through the thoracic and cephalic ganglia, they have caused in many insects resistance and especially in mosquitoes. It was therefore necessary to find an insecticidal preparation which would have an action not only on the usual organs, but also on other organs and systems in order to counteract the appearance of the phenomena of resistance by inducing a rapid lethal action by the destruction of these organs and systems and also on all stages of insect development. This is the subject of the present invention. The composition according to the invention comprises: at least one essential oil comprising at least one acid function; at least one proteolytic enzyme; a surfactant, preferably amphoteric, optionally one or more alcoholations. According to an advantageous embodiment, all the constituent elements of the composition are of plant origin, in particular the proteolytic enzyme and the surfactant. According to the invention, the composition comprises at least one essential oil. It can include a mixture of up to 10 essential oils. Beyond 10 oils, the economic interest is less. A mixture of 4, 5, 6 or 7 essential oils gives good results. These essential oils are selected from the group consisting of Inula helenium, Acalypha indica, Eucalyptus globulus, Vetveria zizanoides, Rollina mucosa, Mentha piperita, Arctium lappa, Eugenia caryophyllata, Pinus sylvestris, Juniperus communis, Melaleuca viridiflora, Carapa guyanensis, Annona muricata, Annona squamosa , Sapendus mukorossi, Pogostemon cablin, Rosmarinus officinalis, Santalum album, Tanacetum vulgare, Tanacetum cinerariifolium, Allium sativum, Satureja montana, Quillaja saponaria, Eucalyptus citriodora. In order to increase the lethal effect, there is added to the preparation according to the invention, powder or an alcoholic solution of Carica papaya latex and or latex of Anana comosus and or latex of Ficus genius, Ficus glabadia, Ficus carica. The latex of these plant species contains potent proteolytic enzymes, namely papain for Carica papaya, bromelain for Anana comosus and ficin for Ficus genius, Ficus glabatia, Ficus carica.
Ainsi, la composition selon l'invention comprend une enzyme protéolytique qui est contenue dans une solution alcoolique de latex de tiges et/ou de fruits verts d'espèces végétales choisies dans le groupe comprenant Anana comosus, Carica papaya, Ficus genius, Ficus glabatia, Ficus carica, et leurs mélanges. Dans le but d'accroître l'efficacité de la préparation selon l'invention et d'accélérer sa biodisponibilité et sa biodégradabilité dans le milieu aquatique et dans les sols, on y adjoint un ou plusieurs tensioactifs d'origine végétale de préférence amphotères tels que la bétaïne, la cocamydropyl, la coco-bétaïne, la cétyl-bétaïne, sans que cette liste soit limitative. Ces tensioactifs proviennent, pour la partie hydrophile, du sucre de la paille de blé, de la betterave et/ou de la canne à sucre et, pour le groupement lipophile, de l'alcool de tourteau de colza, de tournesol ou d'huile de palme. La composition selon l'invention comprend une ou plusieurs alcoolatures de feuilles fraîches, de feuilles séchées et broyées, de baies et de bulbes d'espèces végétales choisies dans le groupe comprenant Allium sativum, Juglans regia, Azadirachta indica, Sambucus nigra, Quillaja saponaria, et leurs mélanges. Thus, the composition according to the invention comprises a proteolytic enzyme which is contained in an alcoholic solution of latex of stems and / or green fruits of plant species chosen from the group comprising Anana comosus, Carica papaya, Ficus genius, Ficus glabatia, Ficus carica, and their mixtures. In order to increase the effectiveness of the preparation according to the invention and to accelerate its bioavailability and biodegradability in the aquatic environment and in the soils, one or more surfactants of plant origin, preferably amphoteric, are added, such as betaine, cocamydropyl, coco-betaine, cetyl betaine, without this list being limiting. These surfactants come, for the hydrophilic part, wheat straw sugar, sugar beet and / or sugar cane and, for the lipophilic group, rapeseed, sunflower oil or oil cake alcohol. of palm. The composition according to the invention comprises one or more alcoholates of fresh leaves, dried and crushed leaves, berries and bulbs of plant species chosen from the group comprising Allium sativum, Juglans regia, Azadirachta indica, Sambucus nigra, Quillaja saponaria, and their mixtures.
Les molécules suivantes ont été identifiées dans les différentes huiles essentielles entrant dans la formulation du produit selon l'invention : Inuline, cétosterole, stigmasterole, damaradiénole, hélénine, alantolactone, isoalantolactone, alantone, acide alantique, R hélénène, acide oléïque, acide linoléïque, acide hexadécinoïque, annomuricatine, citronellal, globulol, pinocarvéol, camphène, fenchène, a-phélandrène, acide benzoïque, vétivérol, vétivène, furfurol, vétivone, acétogénine, goniothalamicine, annonacine, p-cymène, isothuyone, a-thuyone, camphor, acétate de bornyle, acétate de lyratyle, germacrène, davanone, acide caféique, acétate de chrysanthényle, acétate de chrysanthénol, cinéole, myrthénol, a-pinène, terpinène, bornéol, trans-pinocarvéol, acétate de sabinyle, cétones, saponosides, citronellol, acide citronelique, acide glycyrrhétique, sapogénines triterpéniques, acide chlorogénique, acide férulique, acide citrique, acide malique, quercétine, kaempférol, apigénine, herpéritine, lutéoline, acide triterpénique, phénylacétaldéhyde, arctiine, polyacétylène, liguanes, coumarine, benzaldhéyde, polyènes, diène, tétrayne, acide arétique, arctinone, arctinol, arctinal, arctiopicrine, allicine, ajoene, polysulfides paraffiniques, disulfure de diallyle, juglon, carvacrol, thymol, alpha-terpinéole, paracymène, limonène, alpha terpinène, alpha-tuyène, 1-8 cinéole, béta-carryophyllène, béta-bisobolène, alphahimulène, camphre, eugénol, iso-eugénol, méthyl eugénol, acétate d'eugénol, menthol, menthone, acétate de menthyle, acétate de terpényle, cadinène, dipantène, sylvestrène, quercétol, cédrène, cadinène, bornéol, terpinéol, patchoulol, acide benzoïque, acide cinnamique, acide-3- méthylbutanoïque, acide cuminique, verbénone, béta- carryophyllène, acétate de bornyle, santalène, santalol, épisantanol, bergamotol, assimicine. D'autre part, l'électrophorèse a mis en évidence la présence d'esters aliphatiques monoterpinoïdes oxygénés, de sesquiterpinoïdes oxygénés et de diterpènes. On sait que le carbonate de calcium amorphe est dissous par les acides faibles, que la chitine, sous l'action de certains agents chimiques se ramollit et se transforme, que les enzymes protéolytiques désorganisent les protéines, que les tensioactifs diminuent la tension interfaciale entre un liquide et un solide en facilitant l'étalement du liquide. Ils ont en outre la propriété de solubiliser des substances insolubles telles que les huiles essentielles et les huiles végétales par la formation de micelles C'est pour ces raisons que le produit selon l'invention comprendra dans sa composition des huiles essentielles comportant obligatoirement une ou plusieurs fonctions acides, un ou plusieurs tensioactifs de préférence amphotères, une ou plusieurs enzymes protéolytiques, de préférence d'origine végétale et éventuellement une ou plusieurs alcoolatures. L'invention porte également sur un procédé de fabrication d'une préparation insecticide, insectifuge, ovicide, larvicide, nymphicide, telle que décrite ci-dessus suivant lequel les huiles essentielles sont mélangées, de préférence dans un récipient en aluminium, sous agitation constante pendant 6 heures à la température ambiante, de préférence à environ 20°C, puis les tensioactifs, les enzymes protéolytiques et éventuellement les alcoolatures, sont ajoutés progressivement et séparément sous agitation constante pendant 1 heure. L'invention porte également sur l'utilisation d'une composition décrite ci-dessus pour la destruction des 5 insectes volants et rampants, de leurs oeufs, leurs larves, leurs nymphes. La présente invention va être décrite de façon plus détaillée en lien avec les exemples ci-dessous donnés à titre d'illustration uniquement. 10 Exemple 1 The following molecules have been identified in the various essential oils used in the formulation of the product according to the invention: Inulin, ketosterol, stigmasterol, damaradienole, alkenolactone, alantolactone, isoalantolactone, alantone, alanine acid, R-helene, oleic acid, linoleic acid, hexadecinoic acid, annomuricatine, citronellal, globulol, pinocarveol, camphene, fenchene, a-phelandrene, benzoic acid, vetoterol, vettivene, furfurol, vettivone, acetogenin, goniothalamicin, annonacin, p-cymene, isothuyone, a-thuyone, camphor, acetate bornyl, lyratyl acetate, germacrene, davanone, caffeic acid, chrysanthenyl acetate, chrysanthenol acetate, cineole, myrthenol, a-pinene, terpinene, borneol, trans-pinocarveol, sabinyl acetate, ketones, saponosides, citronellol, citronelic acid, glycyrrhetic acid, triterpene sapogenins, chlorogenic acid, ferulic acid, citric acid, acyl malic, quercetin, kaempferol, apigenin, herperitine, luteolin, triterpenic acid, phenylacetaldehyde, arctiin, polyacetylene, liguanes, coumarin, benzaldehyde, polyenes, diene, tetran, aretic acid, arctinone, arctinol, arctinal, arctiopicrin, allicin, ajoene, polysulfides paraffinic, diallyl disulfide, juglon, carvacrol, thymol, alpha-terpineol, paracymene, limonene, alpha terpinene, alpha-tuyene, 1-8-cineole, beta-carryophyllene, beta-bisobolene, alpha-iminene, camphor, eugenol, iso-eugenol, methyl eugenol, eugenol acetate, menthol, menthone, menthyl acetate, terpenyl acetate, cadinene, dipantene, sylvestrene, quercetol, cedrene, cadinene, borneol, terpineol, patchoulol, benzoic acid, cinnamic acid, 3-methylbutanoic acid, cuminic acid, verbenone, beta-carryophyllene, bornyl acetate, santalene, santalol, episantanol, bergamotol, assimicin. On the other hand, electrophoresis revealed the presence of oxygenated monoterpinoid aliphatic esters, oxygenated sesquiterpinoids and diterpenes. It is known that amorphous calcium carbonate is dissolved by weak acids, that chitin, under the action of certain chemical agents, is softened and transformed, that proteolytic enzymes disorganize proteins, that surfactants decrease the interfacial tension between liquid and a solid by facilitating the spreading of the liquid. They also have the property of solubilizing insoluble substances such as essential oils and vegetable oils by the formation of micelles It is for these reasons that the product according to the invention will comprise in its composition essential oils necessarily comprising one or more acid functions, one or more surfactants preferably amphoteric, one or more proteolytic enzymes, preferably of plant origin and optionally one or more alcoholations. The invention also relates to a method of manufacturing an insecticidal, insect repellent, ovicidal, larvicidal, nymphicidal preparation as described above wherein the essential oils are mixed, preferably in an aluminum container, with constant stirring during 6 hours at room temperature, preferably at about 20 ° C, then the surfactants, proteolytic enzymes and optionally the alcoholations, are added gradually and separately with constant stirring for 1 hour. The invention also relates to the use of a composition described above for the destruction of flying and crawling insects, their eggs, their larvae, their nymphs. The present invention will be described in more detail in connection with the examples below given by way of illustration only. Example 1
Dans un mode de réalisation préférentiel le produit selon l'invention a la composition suivante : In a preferred embodiment, the product according to the invention has the following composition:
- Pinus sylvestris 120 ml - Satureja montana 120 ml - Pogostemon cablin 120 ml - Eucalyptus globulus 120 ml - Vetiveria zizanoïdes 120 ml - Eugenia caryophyllata 120 ml - Cedrus atlantica 120 ml - Alcoolature d'Alium sativum 50 ml - Alcoolature de juglans regia 25 ml - Alcoolature de feuille et de fruit de Sambucus nigra 25 ml - Solution alcoolique de latex de Anana comosus 50 ml - bétaïne 10 ml 15 20 25 30 Exemple 2 - Pinus sylvestris 120ml - Satureja montana 120ml - Pogostemon cablin 120ml - Eucalyptus globulus 120ml - Vetiveria zizanoids 120ml - Eugenia caryophyllata 120ml - Cedrus atlantica 120ml - Alcoholic Alium sativum 50ml - Alcoholic juglans regia 25ml - Sambucus nigra leaf and fruit alcohol 25 ml - Anana comosus latex alcohol solution 50 ml - betaine 10 ml 15 20 25 30 Example 2
Dans un autre mode de réalisation le produit selon l'invention a la composition suivante : - Inula helenium 120 ml - Acalypha indica 120 ml - Rollina mucosa 120 ml - Mentha piperita 120 ml - Arctium lappa 120 ml - Juniperus communis 120 ml - Melaleuca viridiflora 120 ml - Alcoolature d'Azadirachta indica 50 ml - Alcoolature d'Allium sativum 25 ml - Alcoolature de Sambucus nigra 25 ml - Solution alcoolique de latex Carica papaya 50 ml - cocamydropyl 10 ml 10 Exemple 3 In another embodiment, the product according to the invention has the following composition: Inula helenium 120 ml Acalypha indica 120 ml Rollina mucosa 120 ml Mentha piperita 120 ml Arctium lappa 120 ml Juniperus communis 120 ml Melaleuca viridiflora 120 ml - Alcoholic Azadirachta indica 50 ml - Allium sativum alcohol 25 ml - Sambucus nigra alcohol 25 ml - Carica papaya latex alcohol solution 50 ml - cocamydropyl 10 ml 10 Example 3
Dans un autre mode de réalisation le produit selon 5 l'invention est composé des éléments suivants : In another embodiment, the product according to the invention is composed of the following elements:
- Carapa guyanensis 120 ml - Annona muricata 120 ml - Annona squamosa 120 ml 10 - Sapendus mukorossa 120 ml - Rosmarinus officinalis 120 ml - Santalum album 120 ml - Tanacetum vulgare 120 ml - Tanacetum cinerariifolium 0,015% 15 - Alcoolature d'allium sativum 45 ml - Alcoolature de juglans regia 25 ml - Alcoolature de feuilles et de fruits de Sambucus nigra 25 ml - Solution alcoolique de latex 20 ficus genius 45 ml - Cétyl bétaïne 10 ml - EDTA 10 ml - Carapa guyanensis 120ml - Annona muricata 120ml - Annona squamosa 120ml 10 - Sapendus mukorossa 120ml - Rosmarinus officinalis 120ml - Santalum album 120ml - Tanacetum vulgare 120ml - Tanacetum cinerariifolium 0.015% 15 - Alcoholic Allium sativum 45ml - Alcoholic juglans regia 25 ml - Alcoholic leaves and fruits of Sambucus nigra 25 ml - Alcoholic latex solution 20 ficus genius 45 ml - cetyl betaine 10 ml - EDTA 10 ml
Afin de mesurer l'efficacité du produit selon 25 l'invention, des tests présomptifs d'efficacité biologique sur plusieurs espèces d'insectes ont été réalisés conformément aux directives EPPO et la directive européenne 91/414/CE. Tous les tests ont porté sur des individus des deux sexes, âgés de 4 à 6 jours, acclimatés 48 heures avant 30 les tests. Les insectes sont préparés à raison de 20 individus par répétition, 4 répétitions sont menées par facteur expérimental. Des individus témoins non traités sont gardés pour contrôle et observés en parallèle pour vérifier la viabilité du matériel vivant. 35 Pour les moustiques les tests ont été menés : en tirs directs, en tests résiduels de surface sur les individus adultes, en tests à la surface de l'eau contre les oeufs, les larves, les nymphes des 3 espèces de moustiques : Aedes 11 aegypti, Anopheles gambiae, Culex pipiens, provenant de souches de laboratoire (origine ORSTOM-OMS) vérifiées annuellement comme sensibles aux principales familles d'insecticides En tirs directs, les insectes sont maintenus dans des cages grillagées et on applique directement le produit selon l'invention, dilué à 3% dans l'alcool cosmétique par pulvérisation avec un vaporisateur à main à raison de 2ml pendant 5 secondes. En tests résiduels de surface, le produit selon l'invention, est appliqué à raison de 50m1 par m2 sur papier filtre Whatmann Fisher de 125mm de diamètre en utilisant un vaporisateur manuel dont on a mesuré le volume mort, pour vérifier la quantité réellement projetée. Les supports traités sont répartis aléatoirement sur une surface de 1m2 traitée de façon homogène. Les insectes sont déposés sur les supports 2 heures après le traitement. Pour la compréhension des résultats, il est nécessaire de définir le KT 100(killing time), qui est le délai nécessaire après traitement pour obtenir 100% de mortalité. Les tests à la surface de l'eau, pour les oeufs, les larves et les nymphes, ont été réalisés de la manière suivante : des bocaux sont remplis de 250m1 d'eau pure tiède dans laquelle sont déposés 20 larves, 20 nymphes, 20 oeufs des 3 espèces et testés séparément. Le produit est appliqué en surface sans agitation à raison de 50 ml par m2. Les exemples de préparation selon l'invention ont été testés selon les mêmes protocoles : Sur des individus adultes mâles de Blattella germanica, origine I.N.A, vérifiés annuellement comme sensibles aux principales familles d'insecticides. Sur des fourmis ouvrières adultes Lasius piger, prélevées de nids sauvages. In order to measure the efficacy of the product according to the invention, presumptive biological efficacy tests on several insect species have been carried out in accordance with EPPO guidelines and European Directive 91/414 / EC. All tests included individuals of both sexes, aged 4-6 days, acclimated 48 hours prior to testing. The insects are prepared at the rate of 20 individuals per repetition, 4 repetitions are carried out by experimental factor. Untreated control individuals are kept for control and observed in parallel to verify the viability of the living material. 35 For the mosquitoes the tests were conducted: in direct fire, in residual surface tests on adult individuals, in tests on the surface of the water against eggs, larvae, nymphs of the 3 species of mosquitoes: Aedes 11 aegypti, Anopheles gambiae, Culex pipiens, from laboratory strains (origin ORSTOM-WHO) checked annually as sensitive to the main families of insecticides In direct fire, the insects are kept in wire cages and the product is applied directly according to the invention, diluted to 3% in the cosmetic alcohol by spraying with a hand spray at a rate of 2ml for 5 seconds. In surface residual tests, the product according to the invention is applied at a rate of 50 ml per square meter on Whatmann Fisher paper filter 125 mm in diameter by using a manual evaporator, the dead volume of which has been measured, to verify the quantity actually projected. The treated supports are distributed randomly over a surface of 1 m 2 treated homogeneously. The insects are deposited on the supports 2 hours after the treatment. To understand the results, it is necessary to define KT 100 (killing time), which is the time required after treatment to obtain 100% mortality. The tests on the surface of the water, for eggs, larvae and nymphs, were carried out in the following way: jars are filled with 250 ml of warm pure water in which 20 larvae, 20 nymphs, 20 eggs of the 3 species and tested separately. The product is applied to the surface without agitation at a rate of 50 ml per m 2. The examples of preparation according to the invention were tested according to the same protocols: On male adult specimens of Blattella germanica, origin I.N.A, verified annually as sensitive to the main families of insecticides. On adult working ants Lasius piger, taken from wild nests.
Sur des termites adultes ouvriers âgés de 4 à 6 jours de l'espèce Reticuliterme santonensis, provenant d'une souche de laboratoire réputée non résistante aux insecticides (Souche Chiberta 1996). On 4- to 6-day-old adult termites of the species Reticuliterme santonensis, from a laboratory strain known to be non-resistant to insecticides (Souche Chiberta 1996).
Pour les moustiques, les résultats ont montré : - en tirs directs : un KT100 de 1 mn - en tests de surface : un KT100 de 4 mn pour Aedes aegypti, 3 mn pour Culex pipiens et 4 mn pour Anopheles gambiae. Pour les tests de surface concernant les larves et les nymphes, les résultats ont montré un KT100 de 30 mn pour les 3 espèces de moustiques, ainsi qu'une viabilité nulle pour tous les oeufs exposés au traitement. On note que quelques soient les espèces, les mortalités des lots témoins sont faibles, voire nulles (<10% comme le requiert la méthode C.E.B.), ce qui autorise l'interprétation des données des lots traités en l'état. En tirs directs, les résultats ont montré : û pour les mouches : un KT100 de 1 mn û pour les blattes : un KT100 de 2mn û pour les fourmis : un KT100 de 10mn û pour les termites : un KT100 de 5 secondes En tests de surface, les résultats ont montré : û pour les mouches : un KT100 de 6 mn û pour les blattes : un KT100 de 60 mn, û pour les fourmis : un KT 100 de 15mn û pour les termites : un KT 100 de 30mn Le produit selon l'invention, dilué à 5% dans de l'alcool cosmétique, a également été testé sur des criquets 25 Locusta migratoria avec pour résultats : - en tirs directs : un KT100 de 10 mn avec un effet d'abattage immédiat ; - en traitement de surface : un KT 100 de 30mn. L'examen macroscopique des individus adultes morts, 30 des mouches, moustiques, blattes, fourmis, termites, montre qu'une grande majorité a perdu la quasi-totalité des ailes et des pattes, que l'abdomen et le céphalothorax sont devenus friables. L'observation du déroulement des essais sur les larves et les nymphes de moustiques a mis en 35 évidence une agitation quasi immédiate de celles-ci, alors même qu'elles n'étaient pas en contact avec la surface. Dès leur remontée à la surface et en contact avec le produit selon l'invention, les larves et les nymphes ont immédiatement coulé sous l'action létale du produit selon l'invention et se sont délitées dans les minutes qui ont suivi. L'examen microscopique a montré un ramollissement de la carapace du thorax et de l'abdomen ainsi qu'une désorganisation tissulaire des organes qu'ils contiennent. Quant aux oeufs, on a pu constater des altérations de l'exochorion, de l'endochorion et de la membrane vitelline pellucide, ce qui explique l'absence d'éclosion. L'observation des cadavres des criquets a montré une cardinalisation et un ramollissement de la carapace ainsi qu'une désorganisation des organes internes du céphalothorax et de l'abdomen, signes d'une transformation physico-chimique structurale de ses composants, qui expliquent la perte des membres et des ailes. For mosquitoes, the results showed: - in direct fire: a KT100 of 1 min - in surface tests: a KT100 of 4 mn for Aedes aegypti, 3 mn for Culex pipiens and 4 mn for Anopheles gambiae. For surface tests on larvae and nymphs, the results showed a 30-minute KT100 for the 3 mosquito species, as well as zero viability for all eggs exposed to treatment. It is noted that, whatever the species, the mortalities of the control batches are low or even zero (<10% as required by the C.E.B. method), which allows the interpretation of the data of the treated batches as they are. In direct fire, the results showed: - for flies: a KT100 of 1 min - for cockroaches: a KT100 of 2 minutes - for ants: a KT100 of 10 minutes - for termites: a KT100 of 5 seconds In tests of surface, the results showed: - for flies: a KT100 of 6 minutes - for cockroaches: a KT100 of 60 minutes, - for ants: a KT 100 of 15 minutes - for termites: a KT 100 of 30 minutes The product according to the invention, diluted to 5% in cosmetic alcohol, has also been tested on Locusta migratoria locusts with the following results: in direct firing: a KT100 of 10 min with an immediate killing effect; - in surface treatment: a KT 100 of 30 minutes. Macroscopic examination of dead adult individuals, flies, mosquitoes, cockroaches, ants, termites, shows that a large majority have lost almost all the wings and paws, and that the abdomen and cephalothorax have become brittle. Observation of the testing of larvae and nymphs of mosquitoes showed almost immediate agitation of the mosquitoes, even though they were not in contact with the surface. As soon as they rose to the surface and in contact with the product according to the invention, the larvae and the nymphs immediately sank under the lethal action of the product according to the invention and broke down in the minutes that followed. Microscopic examination showed softening of the carapace of the thorax and abdomen as well as tissue disruption of the organs they contain. As for the eggs, alterations of the exochorion, the endochorion and the pellucid vitelline membrane have been observed, which explains the absence of hatching. The observation of the locust corpses showed a cardinalization and a softening of the carapace as well as a disorganization of the internal organs of the cephalothorax and the abdomen, signs of a structural physico-chemical transformation of its components, which explain the loss. limbs and wings.
En résumé, l'analyse des résultats des tests d'efficacité biologique du produit selon l'invention, a prouvé que les tensioactifs entrant dans sa composition, provoquent une solubilisation quasi totale des huiles essentielles, augmentent la mouillabilité de la carapace des insectes, favorisent l'action de la fonction acide des huiles essentielles, qui solubilise le carbonate de calcium amorphe combiné à la chitine, la rendant perméable aux enzymes protéolytiques (responsables de la désorganisation des organes internes), aux molécules agissant sur les organes cibles et aux autres composants du produit selon l'invention. La résultante de ces actions combinées explique le fait que les oeufs, les larves et les nymphes perdent leur rigidité, leur faculté de flotter et coulent dans le milieu aquatique. In summary, the analysis of the results of the biological efficacy tests of the product according to the invention has proved that the surfactants used in its composition, cause almost total solubilization of essential oils, increase the wettability of the shell of insects, promote the action of the acid function of essential oils, which solubilizes amorphous calcium carbonate combined with chitin, making it permeable to proteolytic enzymes (responsible for the disorganization of internal organs), to molecules acting on the target organs and to other components of the product according to the invention. The result of these combined actions explains the fact that eggs, larvae and nymphs lose their rigidity, their ability to float and flow into the aquatic environment.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1052630A FR2958500B1 (en) | 2010-04-07 | 2010-04-07 | PREPARATION INSECTICIDE, INSECTIFUGE, OVICIDE, LARVICIDE, NYMPHICIDE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1052630A FR2958500B1 (en) | 2010-04-07 | 2010-04-07 | PREPARATION INSECTICIDE, INSECTIFUGE, OVICIDE, LARVICIDE, NYMPHICIDE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2958500A1 true FR2958500A1 (en) | 2011-10-14 |
| FR2958500B1 FR2958500B1 (en) | 2013-02-08 |
Family
ID=43085777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1052630A Expired - Fee Related FR2958500B1 (en) | 2010-04-07 | 2010-04-07 | PREPARATION INSECTICIDE, INSECTIFUGE, OVICIDE, LARVICIDE, NYMPHICIDE |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2958500B1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106538623A (en) * | 2016-10-31 | 2017-03-29 | 郑州思辩科技有限公司 | A kind of plant and microorganism composite pesticide and preparation method thereof |
| CN108207949A (en) * | 2018-02-01 | 2018-06-29 | 江西省农业科学院农业应用微生物研究所(江西省农村能源研究中心) | A kind of application of alcohol compound in terms of brown paddy plant hopper is prevented |
| CN109400576A (en) * | 2018-12-06 | 2019-03-01 | 中国农业科学院植物保护研究所 | A kind of thiophenes and its application |
| WO2020083913A1 (en) | 2018-10-26 | 2020-04-30 | Citeq B.V. | Biological pest control agent |
| CN111602686A (en) * | 2020-06-15 | 2020-09-01 | 山东省农业科学院植物保护研究所 | A kind of medicinal composition for preventing peanut root rot based on limonene and preparation method thereof |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49125520A (en) * | 1973-04-06 | 1974-12-02 | ||
| JPS5135433A (en) * | 1974-09-18 | 1976-03-25 | Ajinomoto Kk | SATSUCHUZAISOSEIBUTSU |
| JPH0273001A (en) * | 1988-09-08 | 1990-03-13 | Taisho Pharmaceut Co Ltd | Dust improved in fast-acting property against insect pest |
| WO1999018802A1 (en) * | 1997-10-09 | 1999-04-22 | Barrier Biotech Limited | A pesticidal composition |
| KR20020014190A (en) * | 2000-08-16 | 2002-02-25 | 윤광심 | The manufacturing process of pure enviroment as bio-agricultural chemicals by use of exactracted Figue material, chitosan-alginic acid |
| JP2003192516A (en) * | 2001-12-26 | 2003-07-09 | Eco Farm Okinawa Kk | Vermin repellent |
| US6733802B1 (en) * | 1997-12-17 | 2004-05-11 | Fortune Bio-Tech Limited | Natural azadirachtin composition |
| FR2852204A1 (en) * | 2003-03-14 | 2004-09-17 | Georges Camprasse | Universally effective insect repelling and insecticidal product, comprising mixture of aromatic essential oils from 17 species of plants, e.g. Melaleuca viridiflora, Pinus sylvestris and Mentha piperita |
| CN1539295A (en) * | 2003-10-30 | 2004-10-27 | 朱胜一 | Plant parasiticide and its preparation method |
| KR20050082403A (en) * | 2004-02-18 | 2005-08-23 | 윤광심 | The manufacturing process of bio-agricultural chemicals by use of exactracted fig material |
| WO2008037373A2 (en) * | 2006-09-30 | 2008-04-03 | Bayer Cropscience Aktiengesellschaft | Improvement to the biological efficacy of agrochemical compositions on application in the growth substrate suitable formulations and use thereof |
| WO2010088645A2 (en) * | 2009-02-02 | 2010-08-05 | Ecoblend, Llc | Pesticidal compositions and methods of use thereof |
-
2010
- 2010-04-07 FR FR1052630A patent/FR2958500B1/en not_active Expired - Fee Related
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49125520A (en) * | 1973-04-06 | 1974-12-02 | ||
| JPS5135433A (en) * | 1974-09-18 | 1976-03-25 | Ajinomoto Kk | SATSUCHUZAISOSEIBUTSU |
| JPH0273001A (en) * | 1988-09-08 | 1990-03-13 | Taisho Pharmaceut Co Ltd | Dust improved in fast-acting property against insect pest |
| WO1999018802A1 (en) * | 1997-10-09 | 1999-04-22 | Barrier Biotech Limited | A pesticidal composition |
| US6733802B1 (en) * | 1997-12-17 | 2004-05-11 | Fortune Bio-Tech Limited | Natural azadirachtin composition |
| KR20020014190A (en) * | 2000-08-16 | 2002-02-25 | 윤광심 | The manufacturing process of pure enviroment as bio-agricultural chemicals by use of exactracted Figue material, chitosan-alginic acid |
| JP2003192516A (en) * | 2001-12-26 | 2003-07-09 | Eco Farm Okinawa Kk | Vermin repellent |
| FR2852204A1 (en) * | 2003-03-14 | 2004-09-17 | Georges Camprasse | Universally effective insect repelling and insecticidal product, comprising mixture of aromatic essential oils from 17 species of plants, e.g. Melaleuca viridiflora, Pinus sylvestris and Mentha piperita |
| WO2004082358A2 (en) * | 2003-03-14 | 2004-09-30 | Georges Camprasse | Universal insecticide and insect-repellent and method for production thereof |
| CN1539295A (en) * | 2003-10-30 | 2004-10-27 | 朱胜一 | Plant parasiticide and its preparation method |
| KR20050082403A (en) * | 2004-02-18 | 2005-08-23 | 윤광심 | The manufacturing process of bio-agricultural chemicals by use of exactracted fig material |
| WO2008037373A2 (en) * | 2006-09-30 | 2008-04-03 | Bayer Cropscience Aktiengesellschaft | Improvement to the biological efficacy of agrochemical compositions on application in the growth substrate suitable formulations and use thereof |
| WO2010088645A2 (en) * | 2009-02-02 | 2010-08-05 | Ecoblend, Llc | Pesticidal compositions and methods of use thereof |
Non-Patent Citations (9)
| Title |
|---|
| DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MATSUBARA, HIROMICHI ET AL: "Studies on the biological activity of surface-active agents. Part IV. The insecticidal activities of several surface-active agents against adults of the common housefly, Musca domestica L", XP002610735, retrieved from STN Database accession no. 1978:184561 * |
| DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; OGINO, KAZUMASA ET AL: "Quick-acting insecticidal powders containing amphoteric surfactants", XP002610734, retrieved from STN Database accession no. 1990:510950 * |
| DATABASE WPI Week 197538, Derwent World Patents Index; AN 1975-62826W, XP002610737 * |
| DATABASE WPI Week 197619, Derwent World Patents Index; AN 1976-34935X, XP002610736 * |
| DATABASE WPI Week 200347, Derwent World Patents Index; AN 2003-500905, XP002610745 * |
| DATABASE WPI Week 200377, Derwent World Patents Index; AN 2003-819474, XP002610739 * |
| DATABASE WPI Week 200521, Derwent World Patents Index; AN 2005-196687, XP002610738 * |
| DATABASE WPI Week 200674, Derwent World Patents Index; AN 2006-713944, XP002610744 * |
| MEIJO DAIGAKU NOGAKUBU GAKUJUTSU HOKOKU , 13, 12-17 CODEN: MDNGBZ; ISSN: 0910-3376, 1977 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106538623A (en) * | 2016-10-31 | 2017-03-29 | 郑州思辩科技有限公司 | A kind of plant and microorganism composite pesticide and preparation method thereof |
| CN108207949A (en) * | 2018-02-01 | 2018-06-29 | 江西省农业科学院农业应用微生物研究所(江西省农村能源研究中心) | A kind of application of alcohol compound in terms of brown paddy plant hopper is prevented |
| CN108207949B (en) * | 2018-02-01 | 2020-08-04 | 江西省农业科学院农业应用微生物研究所(江西省农村能源研究中心) | Application of alcohol compound in controlling brown planthopper |
| WO2020083913A1 (en) | 2018-10-26 | 2020-04-30 | Citeq B.V. | Biological pest control agent |
| CN109400576A (en) * | 2018-12-06 | 2019-03-01 | 中国农业科学院植物保护研究所 | A kind of thiophenes and its application |
| CN111602686A (en) * | 2020-06-15 | 2020-09-01 | 山东省农业科学院植物保护研究所 | A kind of medicinal composition for preventing peanut root rot based on limonene and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2958500B1 (en) | 2013-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Şengül Demirak et al. | Plant-based bioinsecticides for mosquito control: Impact on insecticide resistance and disease transmission | |
| Abbas et al. | Integrated Strategies for the Control and Prevention of Dengue Vectors with Particular Reference to Aedes aegypti. | |
| Sofi et al. | Larvicidal activity of Artemisia absinthium extracts with special reference to inhibition of detoxifying enzymes in larvae of Aedes aegypti L | |
| Weldon et al. | Anointing chemicals and hematophagous arthropods: responses by ticks and mosquitoes to citrus (Rutaceae) peel exudates and monoterpene components | |
| JP2008515965A (en) | Drugs for managing codling moths in orchards | |
| FR2958500A1 (en) | Insecticide, insect repellent, ovicide, larvicide, nymphicide composition, useful to destruct flying and crawling insects, their eggs, larvae, and nymphs, comprises essential oil, proteolytic enzyme, and amphoteric surfactant | |
| Thomas et al. | The use of garlic (Alliumsativa) and lemon peel (Citrus limom) extracts as Culex pipiens larvacides: Persistence and interaction with an organophosphate resistance mechanism | |
| Ramasamy et al. | Chemical characterization of billy goat weed extracts Ageratum conyzoides (Asteraceae) and their mosquitocidal activity against three blood-sucking pests and their non-toxicity against aquatic predators | |
| Nchu et al. | In vitro investigation of the toxic effects of extracts of Allium sativum bulbs on adults of Hyalomma marginatum rufipes and Rhipicephalus pulchellus | |
| Nyamador et al. | Insecticidal activity of four essential oils on the survival and oviposition of two sympatric bruchid species: Callosobruchus maculatus F. and Callosobruchus subinnotatus PIC.(Coleoptera: Chrysomelidea: Bruchinae) | |
| Dagar et al. | Plant based and synthetic products as mosquito repellents: Effects, target sites and their mechanism of action on mosquitoes | |
| Al-Shuraym et al. | The impact of onion-garlic mixture to control of Rhynchophorus ferrugineus in Saudi Arabia | |
| WO2021064252A9 (en) | Pesticide synergist sx-pyr | |
| CN114929783B (en) | Insect repellent composition | |
| Anaya-Gil et al. | Artificial modification of the chemical composition of orange oil (Citrus sinensis L.) and its effect on larvicidal activity | |
| Ajayi et al. | Bio-activity of three essential oils extracted from edible seeds on the rust-red flour beetle, Tribolium castaneum (Herbst.) infesting stored pearl millet. | |
| WO2020261083A1 (en) | Bed bug control composition and process of preparing the same | |
| KR101918269B1 (en) | Composition for controlling pochazia shantungensis | |
| Subekti et al. | Effective control of Alphitobius diaperinus using natural bioinsecticides: Effective control of Alphitobius diaperinus using natural bioinsecticides | |
| KR100484887B1 (en) | Natural composition of repelling mosquitoes | |
| Gad et al. | A tea tree oil-based nanoemulsion for controlling root-knot nematodes in vitro | |
| Manorenjitha Malar et al. | Repellency effect of white flesh Citrus grandis osbeck fruit peel extracts against Aedes aegypti (Linn.) Mosquitoes | |
| Gargani et al. | The black weevil (Aclees sp. cf. foveatus) of the fig tree: Control trials with plant extracts | |
| Uenoyama et al. | Domestic cats damage silver vine and catnip plants containing iridoids and enhance chemical pest defence | |
| Araujo et al. | Sulfur nanocomposites with insecticidal effect for the control of Bactericera cockerelli (Sulc)(Hemiptera: Triozidae) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| PLFP | Fee payment |
Year of fee payment: 7 |
|
| TP | Transmission of property |
Owner name: MEGA BIO PHARMA, FR Effective date: 20170110 |
|
| PLFP | Fee payment |
Year of fee payment: 8 |
|
| PLFP | Fee payment |
Year of fee payment: 9 |
|
| PLFP | Fee payment |
Year of fee payment: 10 |
|
| PLFP | Fee payment |
Year of fee payment: 11 |
|
| PLFP | Fee payment |
Year of fee payment: 12 |
|
| PLFP | Fee payment |
Year of fee payment: 13 |
|
| PLFP | Fee payment |
Year of fee payment: 14 |
|
| ST | Notification of lapse |
Effective date: 20241205 |